MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MABVAX THERAPEUTICS HOLDINGS, INC. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Sell | S | 0.84 | 17,998 | 15,118 | 64,558 | 82.6 K to 64.6 K (-21.80 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Sell | S | 0.87 | 17,444 | 15,176 | 82,556 | 100 K to 82.6 K (-17.44 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Sell | S | 0.84 | 17,996 | 15,117 | 67,645 | 85.6 K to 67.6 K (-21.01 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Sell | S | 0.87 | 17,445 | 15,177 | 85,641 | 103.1 K to 85.6 K (-16.92 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Sell | S | 0.84 | 17,999 | 15,119 | 68,314 | 86.3 K to 68.3 K (-20.85 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Sell | S | 0.87 | 17,449 | 15,181 | 86,313 | 103.8 K to 86.3 K (-16.82 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Sell | S | 0.84 | 17,996 | 15,117 | 78,355 | 96.4 K to 78.4 K (-18.68 %) | |
| Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Sell | S | 0.87 | 17,444 | 15,176 | 96,351 | 113.8 K to 96.4 K (-15.33 %) | |
| Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.92 | 38,054 | 35,010 | 283,703 | 321.8 K to 283.7 K (-11.83 %) |
| Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.92 | 59,263 | 54,522 | 536,730 | 596 K to 536.7 K (-9.94 %) |
| Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Sell | S | 0.92 | 3,071 | 2,825 | 18,333 | 21.4 K to 18.3 K (-14.35 %) |
| Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.92 | 41,873 | 38,523 | 320,013 | 361.9 K to 320 K (-11.57 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 449,159 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.96 | 11,232 | 10,783 | 361,886 | 373.1 K to 361.9 K (-3.01 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.98 | 38,697 | 37,923 | 373,118 | 411.8 K to 373.1 K (-9.40 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.96 | 66,550 | 63,888 | 411,815 | 478.4 K to 411.8 K (-13.91 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 449,159 | 0 | 478,365 | 29.2 K to 478.4 K (+1,537.90 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Option Exercise | M | 0.00 | 29,944 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Sell | S | 0.96 | 824 | 791 | 21,404 | 22.2 K to 21.4 K (-3.71 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Sell | S | 0.98 | 2,837 | 2,780 | 22,228 | 25.1 K to 22.2 K (-11.32 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Sell | S | 0.96 | 4,879 | 4,684 | 25,065 | 29.9 K to 25.1 K (-16.29 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Buy | M | 0.00 | 29,944 | 0 | 29,944 | 0 to 29.9 K |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | M | 0.00 | 406,382 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.96 | 10,207 | 9,799 | 321,757 | 332 K to 321.8 K (-3.07 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.98 | 35,166 | 34,463 | 331,964 | 367.1 K to 332 K (-9.58 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.96 | 60,478 | 58,059 | 367,130 | 427.6 K to 367.1 K (-14.14 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | M | 0.00 | 406,382 | 0 | 427,608 | 21.2 K to 427.6 K (+1,914.55 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Sell | S | 0.96 | 3,571 | 3,428 | 256,554 | 260.1 K to 256.6 K (-1.37 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Sell | S | 0.98 | 12,301 | 12,055 | 260,125 | 272.4 K to 260.1 K (-4.52 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Sell | S | 0.96 | 21,155 | 20,309 | 272,426 | 293.6 K to 272.4 K (-7.21 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Buy | M | 0.00 | 100,000 | 0 | 293,581 | 193.6 K to 293.6 K (+51.66 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | M | 0.00 | 727,210 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.96 | 18,582 | 17,839 | 595,993 | 614.6 K to 596 K (-3.02 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.98 | 64,015 | 62,735 | 614,575 | 678.6 K to 614.6 K (-9.43 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.96 | 110,093 | 105,689 | 678,590 | 788.7 K to 678.6 K (-13.96 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Buy | M | 0.00 | 727,210 | 0 | 788,683 | 61.5 K to 788.7 K (+1,182.97 %) |
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Option Exercise | M | 0.00 | 100,000 | 0 | 1,543 | ||
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K | |
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Option Exercise | M | 0.00 | 100,000 | 0 | 1,543 | ||
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K | |
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | M | 0.00 | 100,000 | 0 | 1,543 | ||
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K | |
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | M | 0.00 | 100,000 | 0 | 1,543 | ||
| Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |